🇪🇺 Ritlecitinib 20 mg in European Union

Ritlecitinib 20 mg (ritlecitinib-20-mg) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Ritlecitinib 20 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Dermatology approved in European Union

Frequently asked questions

Is Ritlecitinib 20 mg approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Ritlecitinib 20 mg in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.